KKR related stories
All articles and analysis
Blackstone, CPPIB to bid on Canadian wireless spectrumThe Canada Pension Plan Investment Board has teamed up with Blackstone and a Canadian telecom company to bid in an upcoming spectrum auction. The consortium has deposited $340 million toward that end.
- TPG to pay $1.3bn for Canadian drug firm(4)
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
- Listed US firms end dismal week
Blackstone, Fortress and Och-Ziff stocks hit all-time lows Friday, as specialised vehicles affiliated with Carlyle and KKR faced problems ranging from fair value write-downs to margin calls and default notices.
- SVG writes down Permira deals to tune of £67m
The listed alternative asset manager incurred losses on its investments in four Permira portfolio companies last year, but its fund management business grew and Permira made ten profitable realisations.
- The transformer
If his firm can't change it, Donald Gogel won't buy it. The CEO of New York buyout firm Clayton, Dubilier & Rice oversees an investment team that has since 1978 combined financial acumen with roll-upyour-sleeves operating work. It is an investment model now pursued by almost every major private equity firm, but Gogel argues that few firms are as committed to the granularity of operational change as is Clayton Dubilier. The former Rhodes scholar spoke recently with David Snow about standing out from the competition, his firm's stepped up co-investment activity and his days as a New York City streetballer.
- Fine for now
Fundraising is proceeding at a fair clip amid signs that even the larger funds are still in favour. It is clear that investors are keeping the faith. But will they do so indefinitely, asks Andy Thomson?
- Graphite recruits fund of funds veteran
The mid-market buyout firm and fund of funds has recruited Dana Haimoff from JPMorgan as a partner, as Graphite’s listed investment trust trades at a discount on the public markets despite 14.3 percent net asset value gains in 2007.
- TPG to pay $1.3bn for Canadian drug firm(3)
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
- Istithmar takes Barneys for $942m(3)
Dubai-based private equity firm Istithmar has emerged with high-end retailer Barneys New York for a purchase price of $942m, after a month-long bidding war with Japanese clothing retailer Fast Retailing.
- Boots post-buyout accounts reveal £1.55bn dividend(2)
A document published before the accounts released today showed Stefano Pessina, Boots’ executive chairman and the manager at the centre of Kohlberg Kravis Roberts’ take-private, would reap £600 million from the delisting.